"Taming the Shapeless Monster: A Breakthrough in Cancer Research"

Researchers at UC Riverside have developed a peptide that can control the MYC protein, which is involved in 75% of human cancers. This breakthrough offers hope for more effective cancer treatments at a molecular level. The peptide binds to MYC, suppressing its activity and potentially opening new avenues for drug development. The team is also working on improving the peptide's delivery into cells, with the goal of inhibiting MYC's cancer-promoting function. This innovative approach could lead to significant advancements in cancer treatment.